RADX logo
RADX NASDAQ AU

Radiopharm Theranostics Limited - American Depositary Shares

Healthcare · Biotechnology Website · IPO Nov 2021
$4.40
▲ +$0.08 (+1.85%)
Vol 24K
2
Quality Score
fail
Mkt Cap
$88.6M
ROE
-78.3%
Margin
-1055.3%
D/E
0.00
Beta
1.03
52W
$0–$0

Wall Street Consensus

6 analysts · Apr 2026
1
Strong Buy
4
Buy
1
Hold
0
Sell
0
Strong Sell
83.3%
Buy Rating

Price Chart

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -78.2% -103.1% -74.9% -74.9% -78.2% -78.2%
P/E (TTM)
Net Margin -831.2% -11838.5% -1010.1% -1010.1% -1055.3% -1055.3%
Gross Margin 12.0%
D/E Ratio 0.00 0.00 0.00 0.00 0.00 0.00
Current Ratio 2.67 3.37 2.67 2.67 2.67 2.67

Key Ratios

ROA (TTM)
-42.9%
P/S (TTM)
24.39
P/B
1.2
EPS (TTM)
$-0.02
52W High
$0.04
52W Low
$0.02
$0.02 52-Week Range $0.04

How does RADX compare to Biotechnology peers?

Peer group: Micro-cap Biotechnology (All) · 528 companies

RADX AAPG ABEO ABOS ABP

RADX valuation vs Biotechnology peers

P/E ratio
0% below peers (18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
24.4
90% above peers (12.9)
vs Peers
vs Industry
Pricier
P/B ratio
1.2
53% below peers (2.5)
vs Peers
vs Industry
Undervalued
Div yield
0% below peers (0.0%)
vs Peers
vs Industry
Low yield

RADX profitability vs Biotechnology peers

ROE
-78.3%
16% below peers (-67.3%)
vs Peers
vs Industry
Below avg
Net margin
-1055.3%
268% below peers (-286.8%)
vs Peers
vs Industry
Weak
Gross margin
0% below peers (78.6%)
vs Peers
vs Industry
In line
ROA
-42.9%
8% above peers (-46.7%)
vs Peers
vs Industry
In line

RADX financial health vs Biotechnology peers

D/E ratio
0.0
0% below peers (0.0)
vs Peers
vs Industry
Low debt
Current ratio
2.7
40% below peers (4.4)
vs Peers
vs Industry
Low liquidity
Beta
1.0
6% above peers (1.0)
vs Peers
vs Industry
Less volatile

RADX fundamentals radar

RADX Peer median Industry

RADX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

RADX vs peers: key metrics

Latest News

No related news yet